LATEST NEWS

September 2026

Persista Bio Receives Positive Feedback on Modular Approach from FDA INTERACT

July 2026

Persista Bio awarded FuzeHub Manufacturing Grant

September 2025

Persista Bio Secures Two NIH Grants to Advance O2Line™ Oxygenated Cell Therapy Platform

August 2025

Nature Communications: Study demonstrates effectiveness of Persista Bio’s oxygen-supported cell encapsulation technology for diabetes therapy

May 2025

Diabetes reversed in rats in latest research

OCTOBER 9

Persista Bio CEO to present at Meeting on the Mesa

Cell and Gene Meeting on the Mesa, October 7-9, 2024, Phoenix

https://meetingonthemesa.com/

OCTOBER 29

IPITA Conference to include a presentation by Dr. Minglin Ma

IPITA Stem Cell Conference, Oct 28-29, 2024, Boston

https://stemcellislet.ipita.org/program/detailed-program

September 3, 2024

Dr. Minglin Ma is a co-author on a newly published review of diabetes cell therapies

Minglin Ma is co-author of “Harnessing Cellular Therapeutics for Type 1 Diabetes Mellitus: Progress, Challenges, and the Road Ahead” in the journal Nature Reviews Endocrinology.